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Abstract. Preterm birth (PTB) is a significant health problem globally, with an estimate of 15 million cases annually.
Approximately 10% of neonates born early will die prematurely, while a subset will develop severe life-long morbidities.
Unfortunately, preterm birth’s syndromic nature has evaded prevention strategies, and it continues to impose a high burden on
healthcare systems and families. The role of vaginal bacteria in triggering biomolecular causes of PTB has been recognised
for years. However, translating this knowledge to practical diagnostic and therapeutic strategies has remained elusive. New
techniques in high-throughput sequencing have improved our understanding of the nature and role of the vaginal microbiome
during pregnancy. Several multi-ethnic andmulti-geographical studies into the vaginal microbiome have identified five distinct
bacterial profiles termedcommunitystate types (CSTs),oneofwhich ispositivelyassociatedwithdysbiosisand increased riskof
PTB. In a small pilot study of first-trimester vaginal microbial DNA obtained from pregnant women at high-risk of PTB, we
compared the CST profiles generated using standard 16S amplicon sequencing with shallow shotgun metagenomics (SSM).
Bothmethods identified thepresenceof thefiveCSTsashasbeen reportedpreviously, although themetagenomicdata showed
greater taxonomic resolution and more accurate CST assignation. These findings suggest that SSM is a cost-effective and
potentially superior alternative to 16S sequencing for vaginal microbiome analysis.
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Introduction
Preterm birth (PTB), defined by the World Health Organization as all
deliveries between 20–37 weeks of completed gestation, is a com-
plex syndrome. The condition is divided into four groups based on
gestational age (GA) at of birth: extreme PTB (<28 GA), very PTB
(28-32 GA), moderate PTB (32-34 GA) and late PTB (34-37 GA)1.
PTB impacts the lives of 15 million families annually, with an
approximate 10% mortality rate in the first month after delivery2.
Despite advances in neonatal care and improved survival and
reduced morbidity, preterm infants are at high risk of developing
metabolic disorders and debilitating neurological conditions, such as
blindness, deafness, neurodevelopmental delays, and behavioural
issues well into adulthood3. A recent meta-analysis of PTB hospi-
talisation costs in the US, Canada, and The Netherlands reported that
the individual healthcare costs for extreme PTB were between
$111 152–$576 972 per delivery4.
PTB is a syndrome that is both difficult to predict and to prevent5.
Multiple methods and approaches for PTB prediction have been
developed and evaluated, with varying success6–9. Similarly, pre-
ventative treatments are limited and lack the required efficacy,
applicability and precision. Women identified as at high risk of
PTB (typically due to either a previous PTB and/or a short cervical
length defined as <25 mm) typically receive one of two clinically-
recommended preventive interventions at the discretion of the
treating obstetrician, namely exogenous progesterone (vaginally,
orally or intramuscularly) or cervical cerclage surgery10.
A meta-analysis from 2018 with large high-risk pregnancies
cohorts report that vaginal progesterone (VP) use resulted in a
pooled relative risk ratio (RR) of 0.29–0.68, while cervical cerclage
had a RR of 0.64–0.7011. The effectiveness of VP appears to be
particularly robust in high-risk women with short cervical length
(<25 mm), as has been recently demonstrated in the EPPPIC
meta-analysis12.
PTB has long been known to be associated with ascending
intrauterine infections originating from a dysbiotic (sub-optimal)
lower vaginal tract microbiome5,13,14. In 2–27% of pregnant women,
the microbiome composition shifts to an increase in species
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diversity, leading to a dysbiotic vaginal microbiome associated with
a disease state. Several studies have now show that an increase in
bacterial diversity is linked to reproductive tract inflammation and
increased risk of PTB15–19. Despite numerous studies investigating
the predictive usefulness of vaginal microbiome analysis, the diag-
nostic utility of this approach remains elusive. In a recent large study
of low-risk Australian women, a high-risk microbial profile in the
2nd trimester was identified based on the presence/absence and
combinations of known bacterial species18. Notwithstanding this
study’s clinical relevance to PTB management, it is important to
point out that this particular work is based on analysis of a selected
number of risk-associated bacteria, not the entire microbiome per se.
In 2011, Ravel and colleagues classified the vaginal microbiome of
healthy reproductive-age women into five distinct community state
types (CST), conditional on the dominance of oneof fourLactobacillus
spp. or lack thereof. CST-I is dominated by Lactobacillus crispatus,
CST-II by Lactobacillus gasseri, CST-III by Lactobacillus iners,
CST-IV by diverse anaerobic bacteria resembling the clinically
diagnosed condition of bacterial vaginosis (BV), and CST-V by
Lactobacillus jensenii20. The robustness of CST classifications has
since been confirmed in many human microbiome studies, regardless
of ethnicity, geographical location or sequencing methodology21.
More recently, the Ravel laboratory developed the tool
‘VALENCIA’ (VAginaL community state typE Nearest CentroId
clAssifier), which unbiasedly affirmed the presence of the original
broad five CST profiles while defining an additional set of 13
subCST groups22. Importantly, VALENCIA links CST profiles with
clinical descriptors across multiple ethnicities, plus provides
researchers with the ability to accurately differentiate between
known subtypes of CST-IV. The new CST-IV classification now
takes into account the presence and abundance of Lactobacillus spp.
and the following clinically essential bacteria: Gardnerella vagina-
lis, Bifidobacterium spp., Atopobium vaginae, Prevotella spp.,
Enterococcus spp., Streptococcus spp., and Staphylococcus spp.22.
Notably, in the context of the vaginal microbiome, studies have
shown that CST-IV and CST-III dominance early in pregnancy
increase the risk of PTB18,23, and it is now believed that microbial
diversity assessment and CST profiling may help screen women for
PTB risk17. Despite solid evidence associating PTB with CST sub-
optimal profiles, it is worth mentioning that most of the evidence was
from studies with a predominantly Caucasian cohort. In African
American cohorts, the associated significance was weak or disap-
peared altogether24.
With the acceptance of ethnicity as a significant confounding
factor, we know that vaginal microbiome dysbiosis is a substantial
risk factor for uterine ascending infection, which has been causally
linked to up to 40% of all preterm births5. However, the techniques
used to generate microbiome data are often constrained by limited
financial and bioinformatic resources, limiting their clinical and/or
diagnostic utility. Therefore, employing methods that increase
taxonomic resolution at a reasonable cost have the potential to
enable CST profiling to be conducted for PTB risk prediction and
treatment in high-risk pregnancies, as well as increasing the accu-
racy and resolution of the data.
Presently, the vaginal microbiome is typically studied via two
DNA-based approaches and one RNA-based strategy: metabarcod-
ing (DNA), metagenomics (DNA) and, to a lesser extent, metatran-
scriptomics (RNA, not discussed further)25. Metabarcoding (also
known as metataxonomics or amplicon sequencing) is the most
commonly used technique for microbiome analysis, partly due to its
simplicity, but primarily because of the low cost (typically <$100 per
sample) and well established analysis pipelines (e.g. USEARCH/
DADA2). Amplicon sequencing involves the PCR amplification of a
small hypervariable region or regions (250–500 bp) of the taxo-
nomically informative 16S rRNA gene expressed in all bacterial
species. Typically, microbiome specialists would design primers that
can amplify a set of variable regions that allow the taxonomic
discrimination and identification of bacterial genera – in some cases
to the species level; this is necessary for CST profiling, although bias
can be introduced through primer design, the selected 16S rRNA
gene region and its coverage25. To eliminate obvious bias, primers
may need to be redesigned to increase the species detection within the
same taxonomic kingdom,or if separate domains are tobe targeted, such
as when characterising the prokaryotes, fungi and microeukaryotes
communities present in the human vaginal tracts25,26.
In contrast, metagenomics or shotgun sequencing has significant
advantages over amplicon sequencing. It can remove detection bias
by sequencing all DNA present in a sample, providing taxonomy to
strain-level accuracy. Furthermore, it provides the researcher with
the ability to assess metabolic functional potential of the genomes
by conducting pathway analysis based on the sequenced genes.
Although standard shotgun sequencing has advantages over
amplicon sequencing, it carries some critical disadvantages: (1) the
amount of DNA required is at least 1 mg; (2) analysis is expensive
($500–$1000 each); and (3) there is a requirement to have access
to specialist bioinformatics resources and high-performance
computing27.
We have recently completed a pilot study assessing the taxo-
nomic resolution resulting from a recent methodological advance
in metagenomic analysis called shallow shotgun metagenomics
(SSM)28,29. In SSM a sample is typically sequenced to a depth
<1 million reads, which is an order of magnitude or more lower than
the depth expected in a standard metagenomics study (depth between
10 million to 2.5 billion reads)29. The reduction in sequencing depth
reduces the cost of SSM to those similar to amplicon sequencing,
while retaining broad taxonomic coverage at higher taxonomic
resolution with functional genetic information. Hillman and collea-
gues recently showed that a sequencing depth as low as 100 000
reads can mirror >90% of the alpha diversity and gene functional
capacity relative to that mapped by ultra-deep metagenomics28.
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These attributes make SSM ideal for the study of microbiomes in
large, longitudinal cohorts.
SSM also has two important practical limitations. Firstly, if a
sample type contains a very high host:microbe DNA ratio, such as
found in blood or tissue biopsies, then SSM may not be the method
of choice, because the dominance of host DNA will swamp the reads
assigned to microbes and low abundance species may be missed.
Secondly, there are bioinformatic constraints, as most available tools
are not designed to meet the particular requirements of SSM-
generated data; this can result in the generation of false positives
and negatives. Additionally, the entire metagenomics field is limited
by the availability of high-quality genome databases due to the
infancy of this field. Thus, rare or non-sequenced organisms are
reported as negative or unassigned, potentially losing important
taxonomic information and compromising interpretation. Although
these points are all important limitations to consider in study
design, in some microbiomes such as the skin or the vaginal
microbiome (our research area) that contain a higher host DNA but
low-to-medium biomass, SSM may still offer significant advantages
due to the medical importance of identifying bacteria, fungi, viruses
and micro-eukaryotes to species or strain resolution, which is not
provided by amplicon sequencing.
In this study, we compared the bacterial taxonomic profile of
SSM to standard 16S amplicon sequence in the context of the vaginal
microbiota. The comparison was made using two sample sets: (1) a
mock vaginal community consisting of six vaginal bacterial species
with an even abundance of 16.7% to validate the robustness of the
pipeline; and (2) DNA from 22 high vaginal swabs collected from
women at high risk of PTB during their first trimester in Perth,Western
Australia; the swabs were obtained from the Western Australian
Pregnancy Biobank, with informed consent and institutional ethical
approval.Our swabs yieldedDNAconcentrations between 1–40ng/mL;
two samples and the negative controls did not have enough DNA for
sequencing, and thus were eliminated from analysis. The host DNA in
the remaining 20 samples acquired on average 89% of the MiSeq
Illumina sequenced reads, leaving only 2.1 million reads for the
analysis of 20 samples (plus a mock community control).
Mock community analysis
First, we gauged the performance of our methods using the Amer-
ican Type Culture Collection (ATCC) standardized even abundance
vaginal bacteria mock community (ATCC MSA-1007 medically
relevant species). The sequencing comparison yielded a highly
correlative bacterial composition (Figure 1). The data generated by
amplicon sequencing (using primers targeting the v4 16S rRNA gene
region) vs. SSM showed excellent taxonomic agreement, although
there were some minor differences in relative abundance. However,
it is worth mentioning that the (515f/806r) v4 primers used here were
designed to enable detection of all six species and thus would be
expected to amplify them preferentially. Mycoplasma hominis was
markedly underrepresented in the Met (metagenomics) group where
it represented only 1% of total species, while in the Amp (amplicon)
group it was detected at 19% – very similar to the expected 16.7% in
the mock community. We attribute this discrepancy in theMet group
to the unavoidable stochasticity/compositionality introduced during
sequencing, where the abundance of a species can be heavily skewed
at random. Additionally, in this study we applied a completely PCR-
free library preparation method to avoid amplification bias; however,
this approach required a considerable amount (>100–1000 ng total)























































Figure 1. Mock community bacterial species relative abundance differences between amplicon (Amp) and SSM (Met) sequencing methods.
The table on the right corresponds to the relative abundance on a scale from 0–1 (rounded to 2 decimal places).
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product (4 ng/mL). This does not offer a full explanation as to why
the rest of the species in the mock community were not also detected
at lower proportions than expected. We believe the difference is
most likely driven by the fundamentally different genome-based
reference database and tool used to assign taxonomy in SSM
compared to the widely used extensive options available for bacterial
amplicon sequencing. Interestingly, other studies comparing the
outcome of mock communities and metagenomics also showed that
amplicon sequencing seem to provide closer compositional agree-
ment30. Importantly, this artificial situation would be unlikely to be
replicated in a real-life analysis of complex, natural bacterial
communities.
Vaginal swab analysis
Although the amplicon method showed considerable agreement on
the taxonomic assignments of mock species, the SSM approach
when applied to vaginal samples provided a species or strain level
taxonomic assignation with high confidence as required for accurate
vaginal CST determination. Figure 2 shows the relative abundance
of the top 30 species in the 20 vaginal samples according to the two
methods. While there was general agreement in the relative
abundance of the most common species, several less abundant
species were absent in the Amp group (e.g. Neisseria gonorrhoeae).
In addition, amplicon sequencing could not resolve the genus
Bifidobacterium to species level, while SSM identified the species
as B. longum. We also found that L. iners abundance was overrep-
resented in amplicon sequencing profiles. In contrast, SSM was able
to resolve the same samples to either L. jensenii or L. ultunensis
dominance. Enrichment of L. iners detection in the Amp group can
be explained by preferential primer amplification.
As shown by amplicon sequencing, taxonomic uncertainty can be
problematic to vaginal microbiome profiling, because it can distort
the accurate picture of community composition and structure. In our
analysis of CST profiles, we identified that these inaccuracies can
result in CST-V or CST-IV being wrongly labelled as CST-III. This
was evident in the sample from one patient (M65), whose profile was
dominated by L. ultunensis as detected by SSM, but designated
CST-III by amplicon sequencing (refer to Figure 3).
Although the detection of atypical CST types such as those
dominated by species L. ultunensis/amylovorus posed a challenge
during the allocation of CSTs, the fact that Gardnerella vaginalis






























































Top 30 bacterial species relative abundance
Figure 2. Shallow shotgun metagenomics (Met) provides greater taxonomic resolution than amplicon sequencing (Amp). The figure shows the
aggregated species level taxonomy of all 20 samples for both Met and Amp methods. The bar plot shows the relative species abundance of
patient vaginal samples resulting from the two methods. The X-axis shows the comparison groups with a prefix denoting the microbial survey
approach used. Y-axis represents the relative abundance of sequencing reads assigned to each species. The legend on the right shows the top
30 bacterial species ordered according to the read abundance. Species with abundance smaller than the top 30 are grouped under ‘Other’.
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allocate them to CST-IV (mixture of facultative anaerobes with a
moderate abundance of G. vaginalis). We took this approach to help
in differentiating the atypical group dominant samples from other
Lactobacillus dominated CST types commonly associated with
vaginal microbial health. Although amplicon sequencing generates
considerably lower taxonomic resolution than SSM, we believe it
remains helpful as a tool for vaginal microbiome characterisation
because it can broadly differentiate between CST types on Lacto-
bacillus spp. dominance. Nonetheless, this comparison highlights
the limitations of using amplicon sequencing in accurately distin-
guishing between closely related CST profiles such as those dom-
inated by the Lactobacillus genus.
In conclusion, our pilot study suggests that shallow shotgun meta-
genomics is a superiormethod compared to amplicon sequencing in the
context of species-level vaginalmicrobiome characterisation related to
health anddisease. Importantly,while standard (deep)metagenomics is
cost-prohibitive for large studies, in this pilot study we show that the
benefits associated with sequencing all DNA in a sample can be
achieved at costs similar to amplicon sequencing. Our study also
suggests that the vaginal microbiome data and CST demographics
generatedbyhigh-resolution shotgunmetagenomicsmayneed to be re-
examined in the context of microbial health and disease risk. Our
follow-up work intends to improve our microbiome data accuracy and
confidence by complementing shallow metagenomics laboratory
workflowwith a site-specific, multi-kingdom reference database com-
bined with alternative bioinformatics algorithms.
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